Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Ryerson

Showing results (21-30 of 326) with videos related to

Pageof 33
Sort By:
The European Respiratory Journal|October 16, 2025
SABRE: a sharper tool for prognostication in pulmonary fibrosisDaniel-Costin Marinescu, Christopher J Ryerson
American Journal of Respiratory and Critical Care Medicine|September 2, 2021
Endobronchial Optical Coherence Tomography for the Diagnosis of Fibrotic Interstitial Lung Disease: A Light at the End of the Tunnel?Daniel-Costin Marinescu, Christopher J Ryerson
American Journal of Respiratory and Critical Care Medicine|June 27, 2024
Longitudinal Evaluation and Subgroup Evaluation of Cough Severity in Fibrotic Interstitial Lung DiseaseYet H Khor, Christopher J Ryerson
Current Opinion in Pulmonary Medicine|July 23, 2013
Update on the diagnosis and classification of ILDChristopher J Ryerson, Harold R Collard
Respirology (Carlton, Vic.)|April 5, 2023
Gait speed in idiopathic pulmonary fibrosis: Quickly stepping in the right directionYet H Khor, Christopher J Ryerson
International Journal of General Medicine|October 10, 2015
Managing comorbidities in idiopathic pulmonary fibrosisBlair G Fulton, Christopher J Ryerson
Archivos De Bronconeumologia|December 2, 2025
Defining Progressive Pulmonary Fibrosis: Implications for Clinical Trials, Guidelines, and Patient CareAlyson W Wong, Christopher J Ryerson
The European Respiratory Journal|November 9, 2023
Reply: The concept and application of the treatable traits approach in interstitial lung disease and other chronic respiratory diseasesYet H Khor, Christopher J Ryerson
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
Advancing Drug Development in Idiopathic Pulmonary Fibrosis: Tomorrow Is NowYet H Khor, Christopher J Ryerson
The Lancet. Respiratory Medicine|October 4, 2019
Transbronchial lung cryobiopsy in ILD: the data we've been waiting forChristopher J Ryerson, Kerri A Johannson
Pageof 33

Showing results (21-30 of 326) with videos related to

Sort By:
Pageof 33
The European Respiratory Journal|October 16, 2025
SABRE: a sharper tool for prognostication in pulmonary fibrosisDaniel-Costin Marinescu, Christopher J Ryerson
American Journal of Respiratory and Critical Care Medicine|September 2, 2021
Endobronchial Optical Coherence Tomography for the Diagnosis of Fibrotic Interstitial Lung Disease: A Light at the End of the Tunnel?Daniel-Costin Marinescu, Christopher J Ryerson
American Journal of Respiratory and Critical Care Medicine|June 27, 2024
Longitudinal Evaluation and Subgroup Evaluation of Cough Severity in Fibrotic Interstitial Lung DiseaseYet H Khor, Christopher J Ryerson
Current Opinion in Pulmonary Medicine|July 23, 2013
Update on the diagnosis and classification of ILDChristopher J Ryerson, Harold R Collard
Respirology (Carlton, Vic.)|April 5, 2023
Gait speed in idiopathic pulmonary fibrosis: Quickly stepping in the right directionYet H Khor, Christopher J Ryerson
International Journal of General Medicine|October 10, 2015
Managing comorbidities in idiopathic pulmonary fibrosisBlair G Fulton, Christopher J Ryerson
Archivos De Bronconeumologia|December 2, 2025
Defining Progressive Pulmonary Fibrosis: Implications for Clinical Trials, Guidelines, and Patient CareAlyson W Wong, Christopher J Ryerson
The European Respiratory Journal|November 9, 2023
Reply: The concept and application of the treatable traits approach in interstitial lung disease and other chronic respiratory diseasesYet H Khor, Christopher J Ryerson
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
Advancing Drug Development in Idiopathic Pulmonary Fibrosis: Tomorrow Is NowYet H Khor, Christopher J Ryerson
The Lancet. Respiratory Medicine|October 4, 2019
Transbronchial lung cryobiopsy in ILD: the data we've been waiting forChristopher J Ryerson, Kerri A Johannson
Pageof 33